NCT07807241
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07807241
Title A Study of MX006 in Patients With Advanced and/or Metastatic Tumors Known to Express B7-H3
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Myricx Pharma Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR

Facility Status City State Zip Country Details
Florida Cancer Specialists RECRUITING Sarasota Florida 34232 United States Details
Winship Cancer Institute, Emory University RECRUITING Atlanta Georgia 30322 United States Details
University of Maryland Greenebaum Comprehensive Cancer Center RECRUITING Baltimore Maryland 21201 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
NEXT Oncology RECRUITING San Antonio Texas 78229 United States Details
NEXT Oncology Virginia RECRUITING Fairfax Virginia 22031 United States Details
Royal Marsden NHS Foundation Trust RECRUITING Sutton Surrey SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field